Connection

Charles Bennett to Platelet Aggregation Inhibitors

This is a "connection" page, showing publications Charles Bennett has written about Platelet Aggregation Inhibitors.
  1. Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov; 38(8):845-53.
    View in: PubMed
    Score: 0.340
  2. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl. 2009 Feb; (112):S20-4.
    View in: PubMed
    Score: 0.262
  3. Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol. 2007 Sep 18; 50(12):1138-43.
    View in: PubMed
    Score: 0.238
  4. Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke. 2004 Feb; 35(2):533-7.
    View in: PubMed
    Score: 0.184
  5. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med. 2000 Jun 15; 342(24):1773-7.
    View in: PubMed
    Score: 0.144
  6. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention. Arch Intern Med. 1999 Nov 22; 159(21):2524-8.
    View in: PubMed
    Score: 0.138
  7. Ticlopidine and TTP after coronary stenting. JAMA. 1999 Nov 10; 282(18):1717; author reply 1718-9.
    View in: PubMed
    Score: 0.138
  8. Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre-ibrutinib era: Incidence and risk factors. Cancer Med. 2019 05; 8(5):2233-2240.
    View in: PubMed
    Score: 0.133
  9. Cost-effectiveness model of a phase II clinical trial of a new pharmaceutical for essential thrombocythemia: is it helpful to policy makers? Semin Hematol. 1999 Jan; 36(1 Suppl 2):26-9.
    View in: PubMed
    Score: 0.130
  10. Thrombotic thrombocytopenic purpura after stenting and ticlopidine. Lancet. 1998 Sep 26; 352(9133):1036-7.
    View in: PubMed
    Score: 0.128
  11. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med. 1998 Apr 01; 128(7):541-4.
    View in: PubMed
    Score: 0.124
  12. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007 May 09; 297(18):1992-2000.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.